A randomized, open-label multicentre clinical trial of daily Myrcludex B versus entecavir in patients with HBeAg negative chronic hepatitis B.
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Bulevirtide (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Hepatera
- 11 Mar 2014 Status changed from recruiting to active, no longer recruiting based on information reported in a Hepatera media release.
- 06 Mar 2014 Preliminary results are expected in June 2014 according to a Hepatera media release.
- 21 Dec 2012 New trial record